U.S. Specialized REITs Stock News

NYSE:LPG
NYSE:LPGOil and Gas

DorianG (LPG) Stock Still Looks Overvalued On A 7x Five Year Run

DorianG stock has logged very strong long term returns, yet the intrinsic value estimate from a Discounted Cash Flow (DCF) model currently points to a premium price and the broader valuation checks also lean expensive. Over the past 5 years, DorianG has returned about 7x, which sets a high bar for any further upside based purely on valuation. Future cash flow expectations can support the current share price if they are met, but any disappointment in cash generation or capital allocation may...
NYSE:CXM
NYSE:CXMSoftware

DigitalOcean Stock And 2 Software Names Riding Youth Led Digital Communities

Younger generations are reshaping how membership groups work, from long standing organizations like the Freemasons to new digital communities. That shift creates both opportunity and risk for stocks that depend on memberships, subscriptions, and youth engagement. With regulators asking tougher questions and public perception under pressure, investors may want to look closely at companies that can appeal to under 40s while handling reputational and disclosure issues carefully. This article...
NYSE:EME
NYSE:EMEConstruction

Microsoft Stock And 2 Quality Picks Backed by Strong Balance Sheets

With inflation data, energy price swings and shifting central bank signals all pulling at markets, solid company fundamentals matter more than ever. The Solid Balance Sheet and Fundamentals screener focuses on businesses with high return on equity, resilient past performance and sound balance sheets. That combination can help you focus on quality when headlines are noisy and policy paths feel uncertain. In this article, you will see three stocks from this screener that stand out on these...
NYSE:HPE
NYSE:HPETech

Hewlett Packard Enterprise (HPE) Joins TangleLab On A Valuation Gap Investors May Still Question

Hewlett Packard Enterprise (HPE) stock is in focus after the company joined Rigetti Computing and Pittsburgh Supercomputing Center to build TangleLab, an NSF funded hybrid quantum and classical supercomputing testbed. See our latest analysis for Hewlett Packard Enterprise. The TangleLab announcement comes after a period of strong share price momentum for Hewlett Packard Enterprise, with a 30 day share price return of 8.99% and a year to date share price return of 98.18%. The 1 year total...
NasdaqGS:ZM
NasdaqGS:ZMSoftware

Zoom Communications (ZM) Puts APAC Growth In Focus Following Leadership Changes

Zoom Communications (ZM) is back in focus after announcing two leadership changes. Carlos Quaderi will become Head of Asia Pacific on 1 August 2026, while board member William R. McDermott has resigned. See our latest analysis for Zoom Communications. The leadership reshuffle comes as Zoom Communications trades at US$96.07, with a 7 day share price return of 9.18% and a 1 year total shareholder return of 35.37%. The 5 year total shareholder return remains down 74.95%, suggesting recent...
NasdaqGS:TSCO
NasdaqGS:TSCOSpecialty Retail

Tractor Supply (TSCO) Cuts Guidance On Earnings Miss With Valuation Still Up For Debate

Tractor Supply (TSCO) landed back in focus after its latest quarterly report missed revenue and profit expectations. Management cut full year earnings guidance, citing softer discretionary demand, higher fuel costs and drought related pressures. See our latest analysis for Tractor Supply. At a share price of $30.77, Tractor Supply has seen the stock fall 39.46% on a year to date share price return and the 1 year total shareholder return is down 45.49%. This suggests momentum has been fading...
NYSE:AAT
NYSE:AATREITs

Should AAT’s Steady EPS and Reaffirmed Dividend Refocus Investors on Its Income Stability Strategy?

American Assets Trust, Inc. reported its second-quarter 2026 results, with sales rising to US$103.12 million and revenue to US$109.48 million, while net income eased to US$5.18 million and earnings per share held steady at US$0.09. Despite only modest revenue growth and lower six-month net income versus last year, the maintained earnings per share and recently affirmed US$0.34 quarterly dividend highlight management’s focus on income stability for shareholders. With earnings steady on a...
NasdaqGM:FCEL
NasdaqGM:FCELElectrical

FuelCell Energy (FCEL) Pulled Back After An AI Power Rally, Is The Stock Expensive?

FuelCell Energy (FCEL) drew attention after a profit-taking pullback that followed a sharp rally linked to stronger AI data center buildout expectations tied to Microsoft’s recent cloud results. See our latest analysis for FuelCell Energy. Zooming out from the latest pullback, FuelCell Energy’s share price has fallen 8.51% over the last day and 32.24% over the last 30 days. It still shows a 62.36% 90 day share price return and a 164.50% year to date share price return, which translates into a...
NYSE:AZO
NYSE:AZOSpecialty Retail

AutoZone (AZO) Could Be 24% Undervalued On Its Commercial Growth Narrative

AutoZone (AZO) is back on investors' radar after recent share price moves, with the stock last closing at $3,016.25. That puts fresh attention on how its fundamentals line up with the current valuation. See our latest analysis for AutoZone. Recent moves in AutoZone's share price have come after a softer patch, with a 1-day share price return of 0.32% and a 7-day share price return of 1.99%, set against a 30-day share price return that declined 6.27% and a 90-day share price return that...
NYSE:ADT
NYSE:ADTConsumer Services

Is ADT (ADT) Trading At A Discount After A 31% Gain?

ADT stock has delivered a 31.4% gain over the past three years, yet the current valuation checks point to a mixed picture rather than a clear bargain or clear overpricing. The 31.4% three year return suggests ADT has rewarded patient holders and raises the question of how much of that progress is already reflected in the share price. Future cash generation can benefit if ADT continues to convert recurring service revenue efficiently, while any pressure on margins or higher funding needs may...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Monster Beverage (MNST) Draws Attention On Strong Quarter Hopes While Fair Value Looks Tighter

Interest in Monster Beverage (MNST) has picked up as investors focus on expectations for another strong quarter, with recent commentary pointing to solid US demand and faster international growth as key drivers of attention. See our latest analysis for Monster Beverage. Monster Beverage’s latest share price of US$96.38 comes after a mildly softer 1-day share price return. However, the 90-day share price return of 24.97% and 1-year total shareholder return of 63.30% point to momentum that has...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

AI-Driven Security Integration With Tenzai Could Be A Game Changer For Akamai Technologies (AKAM)

Tenzai previously announced it had integrated its autonomous AI hacker platform with Akamai Technologies’ Web Application Firewall, linking automated threat detection directly to Akamai’s edge security defenses for rapid vulnerability mitigation. This collaboration highlights how Akamai’s security stack is becoming embedded in machine-speed cybersecurity workflows, potentially increasing its relevance for AI-driven threat response architectures. We’ll now examine how this AI-driven security...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon Enterprise (AXON) Faces A Fresh Valuation Test As Its Software Story Gains Attention

Axon Enterprise (AXON) stock has moved sharply in recent months, with a strong gain over the past 3 months but a decline over the past month, prompting investors to reassess the company’s recent performance. See our latest analysis for Axon Enterprise. At a share price of US$527.76, Axon Enterprise has recently seen its short term momentum cool, with a 30 day share price return down 11.15%, even though the 90 day share price return is up 31.18% and the 3 year total shareholder return is...
NasdaqGS:ATEC
NasdaqGS:ATECMedical Equipment

Alphatec (ATEC) Stock May Trade Below Fair Value On Sales Growth

Alphatec Holdings stock has fallen 54.1% year to date, yet the latest valuation checks suggest the shares may now be pricing in a lot of that weakness. The key issue for investors is whether the recent rebound hints at a market starting to reassess that view. The stock is down 54.1% year to date, which points to a sharp reset in expectations already reflected in the price. Future growth in spinal surgery volumes can support sentiment, while any setback in execution or higher funding needs...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Cirrus Logic (CRUS) Stock Still Looks Discounted As Cash Flow Holds Up

Cirrus Logic stock has gained 63.2% over the past 5 years, and current valuation work suggests the market price may still sit below an intrinsic value estimate based on a Discounted Cash Flow (DCF) model. A 63.2% total return over 5 years points to solid long term shareholder gains that now need to be weighed against what the intrinsic value estimate implies for further upside. Future cash generation from Cirrus Logic's audio and mixed signal chips can support the valuation if margins and...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix (NFLX) Could Be 12% Undervalued Following Soft Revenue Guidance

Netflix (NFLX) is back in focus after its second quarter earnings met expectations but came with muted revenue guidance, keeping attention on how the stock’s valuation lines up with its softer near term outlook. See our latest analysis for Netflix. Over the past year Netflix’s share price has fallen 38.11% on a total shareholder return basis, with a 1 day share price decline of 2.00% and a 90 day share price return down 22.11%. This points to fading momentum despite ongoing content deals,...
NYSE:PWR
NYSE:PWRConstruction

Quanta Services (PWR) Is Up 6.6% After Raising 2026 Guidance on Record Backlog and Acquisitions – Has The Bull Case Changed?

In late July 2026, Quanta Services reported second-quarter results showing sales of US$9,557 million and net income of US$451.38 million, and raised full-year 2026 guidance to expected revenues of about US$39.3–39.7 billion and net income of about US$1.74–1.82 billion, with diluted EPS forecast between US$11.41 and US$11.92. Management pointed to a record backlog and contributions from four recent acquisitions as key reasons for the stronger outlook and higher earnings guidance, underscoring...
NYSE:SNOW
NYSE:SNOWIT

Why Snowflake (SNOW) Is Up 9.4% After Launching Cortex AI Gateway For Agent Governance

In late July 2026, Snowflake launched Cortex AI Gateway and a wave of security-focused integrations with partners including 1Password, Aembit, Okta, SailPoint, and others to govern, secure, and monitor first- and third-party AI agents, while giving enterprises centralized visibility into AI access and usage. This push to make AI agents auditable, identity-aware, and cost-controlled positions Snowflake as a core control plane for organizations running production-grade AI workloads across...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON (NasdaqGS:VEON) Stock Ignores Profit Rebuild As Digital Momentum Strengthens

VEON stock barely flinched after earnings, slipping about 1% on the day. The market treated this as just another telecom quarter. The numbers tell a different story. Revenue reached about US$1.27b for the quarter and net income came in at US$122m, with basic earnings per share near US$1.75. That is a solid profit print for a business still priced as if its past volatility is the whole story. For investors, the real headline is the squeeze and release in margins. Reported net margin over the...
NYSE:GAM
NYSE:GAMCapital Markets

Is General American Investors Company (GAM) Still Undervalued On Its Semi Annual Earnings?

Why General American Investors Company Stock Is Back in Focus General American Investors Company (GAM) is back on investor radars after filing its semi annual Certified Shareholder Report and releasing earnings for the half year ended June 30, 2026. The report details revenue of US$12.67 million and net income of US$187.19 million for the period, along with updated portfolio holdings that include ASML Holding, GE Vernova, Berkshire Hathaway, Apple and Alphabet. See our latest analysis for...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Guidance and Q3 Outlook

In late July 2026, Illumina reported second-quarter revenue of US$1,159 million, raised its third-quarter outlook to US$1.14 billion–US$1.16 billion, and increased full-year 2026 revenue guidance to US$4.60 billion–US$4.64 billion from its prior US$4.52 billion–US$4.62 billion range. The company’s decision to lift guidance, despite lower year-on-year net income and earnings per share, underscores management’s confidence in clinical sequencing demand and expanding NovaSeq X adoption as key...
NasdaqGS:WWD
NasdaqGS:WWDAerospace & Defense

Are Woodward’s (WWD) Stronger Earnings Masking Growing Strains In Its Free Cash Flow Strategy?

In its past third quarter ended June 30, 2026, Woodward reported sales of US$1,109.71 million and net income of US$146.68 million, with both basic and diluted earnings per share from continuing operations increasing compared with a year earlier. Despite these stronger earnings, the results highlighted pressure on free cash flow margins at a time when the company is investing heavily in electrified aerospace programs. Next, we’ll examine how stronger earnings alongside pressure on free cash...
NYSE:PSN
NYSE:PSNProfessional Services

Parsons (PSN) Stock Looks Discounted On Earnings But Price In Risks

Parsons has had a rough year in the market, with the share price under pressure after cuts to future revenue and profit expectations and the launch of several shareholder investigations. The stock still screens as undervalued on earnings-based checks and carries a mixed overall value score. Over the past 12 months, Parsons shares are down about 40%, which puts recent valuation concerns firmly in focus for investors. Recent contract wins in areas such as AI driven cybersecurity and...
NYSE:BSX
NYSE:BSXMedical Equipment

Why Boston Scientific (BSX) Is Up 5.6% After Mixed Q2, Recall News And Guidance Update

In late July 2026, Boston Scientific reported second-quarter results showing sales rising to US$5,442 million and net income reaching US$907 million, alongside updated guidance calling for 2026 reported net sales growth of about 5.5% to 6.5% and third-quarter growth of about 3% to 5% versus the prior year. At the same time, the company issued a voluntary Class II recall of its Rapid Refill Continuous Injection System due to syringe connection risks, highlighting ongoing product quality and...